Irradiation of localized prostate cancer in the elderly: A systematic literature review

Cancer today [Internet]. [cité 18 juin 2021]. Disponible sur: http://gco.iarc.fr/today/home. Cancer Tomorrow [Internet]. [cité 18 juin 2021]. Disponible sur: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=27&single_unit=50000&age_start=14. Balducci, 1989, Prostate cancer: a model of cancer in the elderly, Arch Gerontol Geriatrics Mars, 8, 165, 10.1016/0167-4943(89)90060-5 PubMed [Internet]. PubMed. [cité 18 juin 2021]. Disponible sur: https://pubmed.ncbi.nlm.nih.gov/. (prostatic neoplasm[MeSH Terms]) AND (elderly) - Search Results - PubMed [Internet]. [cité 15 janv 2022]. Disponible sur: https://pubmed.ncbi.nlm.nih.gov/?term=%28prostatic+neoplasm%5BMeSH+Terms%5D%29+AND+%28elderly%29&filter=years.2000-2022. Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL. Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer. JCO. 1 avr 2011;29(10):1335‑41. Droz, 2014, Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology, Lancet Oncol août, 15, e404, 10.1016/S1470-2045(14)70018-X Droz, 2017, Management of prostate cancer in elderly patients: recommendations of a task force of the international society of geriatric oncology, Eur Urol, 72, 521, 10.1016/j.eururo.2016.12.025 Wildiers, 2014, International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer, J Clin Oncol, 32, 2595, 10.1200/JCO.2013.54.8347 Mohile, 2021, Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study, Lancet, 398, 1894, 10.1016/S0140-6736(21)01789-X Li, 2021, Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial, JAMA Oncol, 7, e214158, 10.1001/jamaoncol.2021.4158 Mohile, 2018, Practical Assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology summary, J Oncol Pract juill, 14, 442, 10.1200/JOP.18.00180 Brassell, 2011, Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes, J Urology, 185, 132, 10.1016/j.juro.2010.09.014 Scosyrev, 2012, Prostate cancer in the elderly: Frequency of advanced disease at presentation and disease-specific mortality, Cancer, 118, 3062, 10.1002/cncr.26392 Schwartz, 2003, Continued undertreatment of older men with localized prostate cancer, Urology, 62, 860, 10.1016/S0090-4295(03)00690-3 Alibhai, 2004, Is there age bias in the treatment of localized prostate carcinoma?, Cancer., 100, 72, 10.1002/cncr.11884 Wong Y-N, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, et al. Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men. :12. Alibhai, 2003, Do older men benefit from curative therapy of localized prostate cancer?, JCO., 21, 3318, 10.1200/JCO.2003.09.034 Bratt, 2015, Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer, Eur Urol, 68, 53, 10.1016/j.eururo.2014.12.026 Yang, 2017, Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer, Cancer., 123, 4832, 10.1002/cncr.30948 Aas, 2020, Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study, Cancer Med, 9, 6646, 10.1002/cam4.3297 Hoffman, 2010, Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer, Cancer., 116, 2590, 10.1002/cncr.24974 Stromberg, 2009, Improved outcome with combined pelvic external beam radiation and HDR boost brachytherapy or IMART compared with conventional external beam prostate radiation for elderly men with high-intermediate to high-risk prostate cancer, Int J Radiat Oncol Biol Phys, 75, S337, 10.1016/j.ijrobp.2009.07.773 Kent, 2019, Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone, Brachytherapy, 18, 313, 10.1016/j.brachy.2019.01.013 Villa, 2003, External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: age is not a problem, Crit Rev Oncol/Hematol, 48, 215, 10.1016/j.critrevonc.2003.05.006 Nguyen, 2010, Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study, Crit Rev Oncol/Hematol, 74, 66, 10.1016/j.critrevonc.2009.04.004 Geinitz, 2005, 3D conformal radiation therapy for prostate cancer in elderly patients, Radiother Oncol, 76, 27, 10.1016/j.radonc.2005.06.001 Okonogi, 2015, Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of age, J Radiat Res, 56, 889, 10.1093/jrr/rrv040 Aghdam, 2019, Self-reported burden in elderly patients with localized prostate cancer treated with stereotactic body radiation therapy (SBRT), Front Oncol, 9, 1528, 10.3389/fonc.2019.01528 Yamazaki, 2018, Radiothrerapy for elderly patients aged ≥75 years with clinically localized prostate cancer-is there a role of brachytherapy?, J Clin Med., 7, 10.3390/jcm7110424 Yamazaki, 2020, Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer - Brachytherapy enhanced late GU toxicity especially in elderly, Clin Transl Radiat Oncol, 25, 67, 10.1016/j.ctro.2020.09.008 Valdivieso, 2015, Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians, World J Urol, 33, 1985, 10.1007/s00345-015-1553-0 Nguyen, 2015, Adverse effects of androgen deprivation therapy and strategies to mitigate them, Eur Urol, 67, 825, 10.1016/j.eururo.2014.07.010 Levine, 2010, Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology, CA Cancer J Clin, 60, 194, 10.3322/caac.20061 Bekelman, 2015, Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer, JCO., 33, 716, 10.1200/JCO.2014.57.2743 Nguyen, 2010, Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations, Int J Radiat Oncol Biol Phys, 76, 337, 10.1016/j.ijrobp.2009.01.045 Dell’Oglio, 2018, External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer, Urol Oncol: Semin Original Investig, 36, 239.e9, 10.1016/j.urolonc.2018.01.004 Stromberg, 2001, Acute and late toxicity in men ≥70 years old compared with men < 70 years old treated with high dose rate prostate brachytherapy boost and pelvic external irradiation for prostate cancer, Int J Radiat Oncol, Biol, Phys, 51, 308, 10.1016/S0360-3016(01)02390-2 Löser, 2019, Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer, Strahlenther Onkol, 195, 374, 10.1007/s00066-018-1380-5 Li, 2019, Thirty-day hospital revisits after prostate brachytherapy: who is at risk?, Prostate Int, 7, 68, 10.1016/j.prnil.2018.03.003 Chen, 2006, Patient and treatment factors associated with complications after prostate brachytherapy, J Clin Oncol, 7 Goineau, 2020, Can comprehensive geriatric assessment predict tolerance of radiotherapy for localized prostate cancer in men aged 75 years or older?, Cancers (Basel), 12, 10.3390/cancers12030635 Fiorica, 2010, Safety and efficacy of radiotherapy treatment in elderly patients with localized prostate cancer: a retrospective analysis, Arch Gerontol Geriatr, 51, 277, 10.1016/j.archger.2009.11.019 Nanda, 2010, Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy, Int J Radiat Oncol Biol Phys., 77, 147, 10.1016/j.ijrobp.2009.04.085 Merrick, 2008, Prostate brachytherapy in men > or =75 years of age, Int J Radiat Oncol Biol Phys, 72, 415, 10.1016/j.ijrobp.2008.01.017 Keating, 2010, Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer, J Natl Cancer Inst, 102, 39, 10.1093/jnci/djp404 Ziehr, 2015, Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer: ADT and cardiac-specific mortality in men with prostate cancer, BJU Int, 116, 358, 10.1111/bju.12905 Baik, 2017, Risk of Alzheimer’s disease among senior medicare beneficiaries treated with androgen deprivation therapy for prostate cancer, J Clin Oncol., 35, 3401, 10.1200/JCO.2017.72.6109 Jayadevappa, 2019, Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.6562 Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 5 (2019) [Internet]. [cité 27 juin 2021]. Disponible sur: https://jnccn.org/view/journals/jnccn/17/5/article-p479.xml. Chen, 2014, Receipt of guideline-concordant treatment in elderly prostate cancer patients, Int J Radiat Oncol Biol Phys, 88, 332, 10.1016/j.ijrobp.2013.11.004 Paillaud, 2018, Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey, Eur J Cancer, 103, 61, 10.1016/j.ejca.2018.07.137